. Author manuscript; available in PMC: 2014 Jan 30.

Published in final edited form as: Eur J Pharmacol. 2012 Dec 21;700(1-3):147–151. doi: 10.1016/j.ejphar.2012.12.006

Table 1.

Primary and Secondary Radioligand Binding Assays

Serotonin Receptors	5-HT_1A, 5-HT_1B, 5-HT_1D, 5-HT_1E, 5-HT_2A, 5-HT_2B, 5-HT_2C, 5-HT₃, 5-HT_5A, 5-HT₆, 5-HT₇
Dopamine Receptors	D₁, D₂, D₃, D₄, D₅
Glutamate Receptors	rNMDA Receptor (MK-801 binding site), mGluR₅
GABA Receptors	rGABA-A, rGABA-B, central and peripheral benzodiazepine sites
Biogenic Amine Transporters	SERT, NET, DAT
Adrenoceptors	α_2A, α_2B, α_2C. β₁, β₂, β₃, α_1A, α_1B, α_1Δ
Cannibinoid	CB₁, CB₂
Muscarinic Receptors	M₁, M₂, M₃, M_4, M5
Opioid Receptors	MOR, KOR, DOR
Sigma Receptors	rSigma₁, rSigma₂
Histamine Receptors	H₁, H₂, H₃, H₄

Shown are the human cloned neurotransmitter receptors, ion channels and transporters assayed in this study except where noted; r=Rat